Xeltis (@xeltis) 's Twitter Profile
Xeltis

@xeltis

Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue.

ID: 3216241983

linkhttp://www.xeltis.com/ calendar_today28-04-2015 08:16:43

1,1K Tweet

721 Takipçi

1,1K Takip Edilen

Xeltis (@xeltis) 's Twitter Profile Photo

Today, Xeltis CEO Eliane Schutte will be attending the European Investment Bank Venture Debt and Advisory Summit in Luxembourg. Eliane will join a panel of esteemed life science leaders to discuss fundraising strategy and the importance of managing the cash runway. #Xeltis #EIB

Xeltis (@xeltis) 's Twitter Profile Photo

Today Xeltis CFO Alexander Goemans will be attending the European Investment Bank ten year Jubliee event in Amsterdam. Alexander will be joining a panel discussing the future of innovation funding and The Netherlands as an innovation leader. #Xeltis #EIB

Xeltis (@xeltis) 's Twitter Profile Photo

This week, Xeltis CEO, Eliane Schutte and CMO, Paulo Neves will be attending VASA's '2024 Vascular Access for Hemodialysis Symposium', May 16-18 in Atlanta, Georgia. They will be joined by leading KOL Matteo Tozzi, MD. Get in touch to set up a meeting!

Xeltis (@xeltis) 's Twitter Profile Photo

Following the CX Symposium in April, Xeltis is delighted for our CEO, Eliane Schutte, to be featured in Pharmaphorums "London’s life sciences scene upbeat as 2024 conference season begins" overview. Read the full article below. pharmaphorum.com/rd/londons-lif…

Xeltis (@xeltis) 's Twitter Profile Photo

Last Tuesday marked 10 years of European Investment Bank's presence in the Netherlands! Our CFO Alexander Goemans, joined a panel at the jubilee event to discuss innovation, capital mobilization, and competitiveness. See some shots of the event below! #EIB #innovation

Last Tuesday marked 10 years of <a href="/EIB/">European Investment Bank</a>'s presence in the Netherlands! Our CFO Alexander Goemans, joined a panel at the jubilee event to discuss innovation, capital mobilization, and competitiveness. See some shots of the event below!

#EIB #innovation
Xeltis (@xeltis) 's Twitter Profile Photo

Last week, CEO Eliane Schutte and CMO Paulo Neves attended the VASA 2024 Vascular Access Symposium in Atlanta. Paulo gave an insightful talk on vascular access trials in Europe, and KOL Matteo Tozzi presented Xeltis' data. See both in action below! #VASA24

Last week, CEO Eliane Schutte and CMO Paulo Neves attended the VASA 2024 Vascular Access Symposium in Atlanta.
Paulo gave an insightful talk on vascular access trials in Europe, and KOL Matteo Tozzi presented Xeltis' data. See both in action below!
#VASA24
Xeltis (@xeltis) 's Twitter Profile Photo

Watch our CEO Eliane Schutte on #OptimumTV! In the interview with Stephen Adams, Eliane discussed Xeltis' Vascular access conduit, aXess, and its potential to transform the lives of dialysis patients with end-stage kidney disease. See the episode below!

Xeltis (@xeltis) 's Twitter Profile Photo

Corporate sustainability platform EcoVadis recently assessed our ESG program and actions, placing us in the top 11% of companies it has rated. This awards Xeltis a Silver rating - reflecting our deep commitment to social and environmental responsibility. #sustainability #ESG

Corporate sustainability platform <a href="/ecovadis/">EcoVadis</a>  recently assessed our ESG program and actions, placing us in the top 11% of companies it has rated. This awards Xeltis a Silver rating - reflecting our deep commitment to social and environmental responsibility.

#sustainability #ESG
Xeltis (@xeltis) 's Twitter Profile Photo

Attention to our Dutch-speaking followers! Our CEO Eliane Schutte recently had the pleasure of being interviewed for the latest episode of the Leaders in Life Sciences Podcast! Have a listen here: leadersinlifesciences.nl/eliane-schutte/

Xeltis (@xeltis) 's Twitter Profile Photo

New YouTube video alert! #aXess is our restorative vascular access conduit which enables the creation of a new, long-term living vessel for hemodialysis vascular access. Subscribe for more via the link! #youtube #vascularaccess #Hemodialysis youtu.be/LgY47yoAg9s?si…

Xeltis (@xeltis) 's Twitter Profile Photo

New YouTube video alert! In this presentation, our CEO, Eliane Schutte, provides an in-depth look at Xeltis' innovative pipeline, highlighting the impressive clinical data behind our lead product, #aXess. Subscribe via the link! youtu.be/cWc4PMFSv0o?si… #youtube #vascularaccess

Xeltis (@xeltis) 's Twitter Profile Photo

Xeltis is gearing up for #LSIEurope24, now less than a week away! CEO, Eliane Schutte, and CFO, Alexander Goemans, will be heading to Portugal from September 16th-20th to take part in presentations and panels. Don’t miss our sessions! See you in Portugal! ☀️

<a href="/Xeltis/">Xeltis</a> is gearing up for #LSIEurope24, now less than a week away!

CEO, Eliane Schutte, and CFO, Alexander Goemans, will be heading to Portugal from September 16th-20th to take part in presentations and panels.

Don’t miss our sessions!

See you in Portugal! ☀️
Xeltis (@xeltis) 's Twitter Profile Photo

See our CFO Alexander Goemans yesterday at #LSIEurope24 during his 'Building Syndicates of Cross-Border Investors in Medtech Companies' panel. If you are also in attendance and would like to connect with Alexander and our CEO Eliane Schutte, please reach out!

See our CFO Alexander Goemans yesterday at #LSIEurope24 during his 'Building Syndicates of Cross-Border Investors in Medtech Companies' panel.

If you are also in attendance and would like to connect with Alexander and our CEO Eliane Schutte, please reach out!
Xeltis (@xeltis) 's Twitter Profile Photo

Our CEO Eliane Schutte participated in a panel and delivered a company presentation at #LSIEurope24 She joined the panel 'The Art and Science of Cross-Border Business Development and Licensing' delivered an in-depth presentation on Xeltis' transformative vascular implants

Our CEO Eliane Schutte participated in a panel and delivered a company presentation at #LSIEurope24

She joined the panel 'The Art and Science of Cross-Border Business Development and Licensing' delivered an in-depth presentation on Xeltis' transformative vascular implants